Why the study?
The liver reflects metabolic alterations linked to cardiovascular risk, but quantifying this risk from liver imaging remains challenging.
Does a deep learning model applied to liver MRI predict major adverse cardiac events in adults?
Does a deep learning model applied to liver MRI predict major adverse cardiac events in adults?
A vision transformer-based deep learning model applied to single-slice liver MRI can predict major adverse cardiac events with performance comparable to established clinical risk scores like SCORE2.
Answers are grounded in this paper and cite their sources.
DL model on liver MRI may aid MACE prediction; leaves open prospective validation and added value beyond SCORE2.
Background & Aims: Cardiovascular mortality remains the leading cause of death and a significant source of morbidity, with metabolic alterations being key etiological factors. As the main metabolic organ, the liver could predict prodromal changes associated with increased cardiovascular risk. However, quantifying this risk remains challenging. This study explores the use of transformer neural networks on liver magnetic resonance imaging (MRI) data to enhance cardiovascular risk prediction. Methods: Using the extensive collection of liver MRIs in the UK Biobank, we developed a feature extractor with a vision transformer backbone trained in a self-supervised manner. This encoder was then used to predict cardiovascular outcomes from liver MRI scans. Unlike traditional methods, no manual feature selection was required, minimizing bias. Performance was assessed via fivefold cross validation, where predicted risk scores were compared against actual cardiovascular outcomes. Conclusions: Vision transformer-based models demonstrate promise as quantifiable biomarkers for cardiovascular risk assessment by capturing subtle metabolic and vascular information from liver MRI scans. These findings highlight their strong predictive performance and potential value in risk stratification. Further prospective studies and external validation will be required to establish their clinical utility. Impact and implications: Our study demonstrates that deep learning applied to liver MRI can predict cardiovascular risk, highlighting the role of the liver as a metabolic indicator of early cardiovascular disease. These findings are significant for clinicians and researchers seeking non-invasive, imaging-based biomarkers for cardiovascular risk stratification, particularly in patients who might not yet exhibit overt symptoms. If validated in prospective studies, this approach could enhance current risk assessment models, allowing for earlier and more personalized interventions in high-risk individuals. However, further validation is necessary before clinical implementation, ensuring broad applicability and integration into existing prevention frameworks.
No takes yet. Share an insight, caveat, or question.
Veldhuizen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: